Literature DB >> 15818743

Vascular contractile response and signal transduction in endothelium-denuded aorta from cirrhotic rats.

Han-Chieh Lin1, Ying-Ying Yang, Yi-Tsau Huang, Tzung-Yan Lee, Ming-Chih Hou, Fa-Yauh Lee, Shou-Dong Lee.   

Abstract

AIM: The mechanism of decreased vascular reactivity to vasoconstrictors in portal hypertension is still unclear. In addition to nitric oxide, defects in post-receptor signal transduction pathway have been suggested to play a role. However, substantial evidences observed equivocal changes of vascular reactivity following different agonists that challenged the hypothesis of the post-receptor defect. The current study was to evaluate the vascular reactivity to different agonists and the inositol trisphosphate (IP(3)) changes in signal transduction cascade from cirrhotic rats with portal hypertension.
METHODS: The endothelial denuded aortic rings from cirrhotic and sham-operated rats were obtained for ex vivo tension study and measurement of the corresponding [(3)H] IP(3) formation following different receptor and nonreceptor-mediated agonists' stimulation. Additionally, iNOS protein expression was measured in thoracic aorta. The contractile response curves to phenylephrine were performed in endothelial denuded aortic rings with and without preincubation with a specific iNOS inhibitor (L-N(6)-(1-iminoethyl)-lysine, L-NIL).
RESULTS: In endothelial denuded aortic rings of cirrhotic rats, the vascular responses were reduced with phenylephrine and arginine vasopressin (AVP) stimulation but were normal with U-46619, NaF/AlCl(3), and phorbol esterdibutyrate (PdBU) stimulation. Compared to the corresponding control groups, the degree of the increment of [(3)H] IP(3) formation from basal level was also decreased with phenylephrine and AVP stimulation, but was normal with U-46619 and NaF/AlCl(3) stimulation. The preincubation with L-NIL did not modify the hyporesponsiveness to phenylephrine. Additionally, the iNOS protein expression in thoracic aorta was not different in cirrhotic and sham-operated rats.
CONCLUSION: Without the influence of nitric oxide, vascular hyporeactivity to vasoconstrictors persisted in cirrhotic rats with portal hypertension. However, the decreased vascular reactivity is an agonist-specific phenomenon. In addition, G-protein and phospholipase C pathway associated with the IP(3) productions may be intact in cirrhotic rats with portal hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818743      PMCID: PMC4305816          DOI: 10.3748/wjg.v11.i15.2306

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  49 in total

1.  Binding studies of platelet alpha 2- and lymphocyte beta 2-adrenoceptors in patients with cirrhosis.

Authors:  A J MacGilchrist; N M Deighton; C A Hamilton; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

2.  Mass measurements of inositol(1,4,5)trisphosphate in rat cerebral cortex slices using a radioreceptor assay: effects of neurotransmitters and depolarization.

Authors:  R A Challiss; I H Batty; S R Nahorski
Journal:  Biochem Biophys Res Commun       Date:  1988-12-15       Impact factor: 3.575

Review 3.  Signal transduction and regulation in smooth muscle.

Authors:  A P Somlyo; A V Somlyo
Journal:  Nature       Date:  1994-11-17       Impact factor: 49.962

4.  Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension.

Authors:  J V Sitzmann; S S Li; P W Lin
Journal:  J Surg Res       Date:  1989-09       Impact factor: 2.192

5.  Reduced vascular sensitivity to norepinephrine in portal-hypertensive rats.

Authors:  J W Kiel; V Pitts; J N Benoit; D N Granger; A P Shepherd
Journal:  Am J Physiol       Date:  1985-02

6.  Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.

Authors:  V Tahan; E Avsar; C Karaca; E Uslu; F Eren; S Aydin; H Uzun; H O Hamzaoglu; F Besisik; C Kalayci; A Okten; N Tozun
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

7.  Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.

Authors:  M Niederberger; P Ginés; P Y Martin; P Tsai; K Morris; I McMurtry; R W Schrier
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

Review 8.  In vitro evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis.

Authors:  P W Hadoke; P C Hayes
Journal:  Pharmacol Ther       Date:  1997       Impact factor: 12.310

9.  The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats.

Authors:  F Y Lee; A Albillos; L A Colombato; R J Groszmann
Journal:  Hepatology       Date:  1992-10       Impact factor: 17.425

10.  Study on the vascular reactivity and alpha 1-adrenoceptors of portal hypertensive rats.

Authors:  J F Liao; P C Yu; H C Lin; F Y Lee; J S Kuo; M C Yang
Journal:  Br J Pharmacol       Date:  1994-02       Impact factor: 8.739

View more
  3 in total

1.  Physiopathology of splanchnic vasodilation in portal hypertension.

Authors:  María Martell; Mar Coll; Nahia Ezkurdia; Imma Raurell; Joan Genescà
Journal:  World J Hepatol       Date:  2010-06-27

2.  Comparative analysis of myometrial and vascular smooth muscle cells to determine optimal cells for use in drug discovery.

Authors:  Shajila Siricilla; Kelsi M Knapp; Jackson H Rogers; Courtney Berger; Elaine L Shelton; Dehui Mi; Paige Vinson; Jennifer Condon; Bibhash C Paria; Jeff Reese; Quanhu Sheng; Jennifer L Herington
Journal:  Pharmacol Res       Date:  2019-05-09       Impact factor: 7.658

3.  Effects of asymmetric dimethylarginine on renal arteries in portal hypertension and cirrhosis.

Authors:  Gloria Segarra; Belén Cortina; María Dolores Mauricio; Susana Novella; Paloma Lluch; Javier Navarrete-Navarro; Inmaculada Noguera; Pascual Medina
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.